CUTR - キュテラ （Cutera Inc.） キュテラCUTRのチャート
CUTRの企業情報
| symbol | CUTR |
|---|---|
| 会社名 | Cutera Inc （キュテラ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 キュテラ(Cutera Inc.)は医療機器会社である。同社は世界中の開業医に提供するレーザーおよびその他のエネルギーベース美容システムの設計、開発、製造、マーケティング、サービスを行う。同社は医師や他の開業医が美容整形の実行を可能にするenlighten、excel HR、truSculpt、excel Vとxeoなどを含む製品プラットフォームを提供する。同社の各レーザーと光ベースのプラットフォームは１つまたは複数のハンドピース、及び１つのグラフィック?ユーザー?インターフェース、１つのレーザーや光ベースのモジュール、制御システムソフトウェアおよび高電圧電子機器を内蔵した１つのコンソールで構成される。同社もCV、ExcelとVantageを含むCoolGlide、Titan S、ProWave 770、OPS 600、LP560、AcuTip 500、Titan V/XLとLimeLightを含むSolera、及び日本市場向けの第三者ソースシステムmyQを提供する。 キュテラは、米国の医療機器メ―カ―。レ―ザ―光治療器をはじめとする医療機器の設計、開発、製造、販売、修理などを行う。主な製品は、美容医療治療器｢ゼオ｣、爪水虫治療器｢ジェネシス・プラス｣、部分痩身器｢トゥル―・スカルプ｣など。本社は、カリフォルニア州ブリスベン。 cutera was established in the san francisco bay area (brisbane) in 1998 by veteran laser and optical engineers. as the pioneer of nd:yag technology, cutera® is the trusted authority in face + body energy-based medical aesthetic technologies that practitioners around-the-world turn to for innovation, sophistication and performance. at cutera, we’re always looking forward; developing new solutions, products and industry-leading services designed around the needs of medical aesthetic community—delivering better results, faster and safer than ever before. cutera’s premium portfolio of products include: xeo®, trusculpt® and excel v™. in 2014, cutera introduced two new exciting additions to their family of premium products: excel hr™ for high-speed, comfortable, hair removal and enlighten™, the industry’s first picosecond + nanosecond + 2 wavelength high-powered laser system. today, our worldwide presence is represented in 40 countries, with direct operations in north america, france, austra |
| 本社所在地 | 3240 Bayshore Blvd. Brisbane CA 94005 USA |
| 代表者氏名 | J. Daniel Plants J.ダニエル・プラント |
| 代表者役職名 | Independent Chairman of the Board |
| 電話番号 | +1 415-657-5500 |
| 設立年月日 | 36008 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2004年 |
| 従業員数 | 367人 |
| url | www.cutera.com |
| nasdaq_url | https://www.nasdaq.com/symbol/cutr |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 0.92300 |
| 終値（lastsale） | 21.435 |
| 時価総額（marketcap） | 296591808 |
| 時価総額 | 時価総額（百万ドル） 279.22660 |
| 売上高 | 売上高（百万ドル） 162.48300 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 250.22160 |
| 当期純利益 | 当期純利益（百万ドル） 32.76400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Cutera Inc. revenues increased 17% to $76.7M. Net loss totaled $3.6M vs. income of $925K. Revenues reflect United States segment increase of 21% to $49.3M. Net loss reflects Selling General_Admin increase of 21% to $27.5M (expense) General_admin exp increase of 49% to $8.5M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $0.07 to -$0.26. |
CUTRのテクニカル分析
CUTRのニュース
CUTR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Cutera, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit 2023/06/07 14:20:00 GlobeNewswire
SAN DIEGO, June 07, 2023 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Cutera, Inc. (NASDAQ: CUTR) common stock between February 17, 2021 and May 9, 2023, both dates inclusive (the “Class Period”) have until July 24, 2023 to seek appointment as lead plaintiff of the Cutera class action lawsuit. Captioned Erie County Employees’ Retirement System v. Cutera, Inc. , No. 23-cv-02560 (N.D. Cal.), the Cutera class action lawsuit charges Cutera as well as certain of its top executives and directors with violations of the Securities Exchange Act of 1934.
CUTR INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Cutera (CUTR) Investors with $100k+ Losses to Contact Firm’s Attorneys, Securities Fraud Class Action Pending 2023/06/06 21:35:00 GlobeNewswire
SAN FRANCISCO, June 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Cutera, Inc. (NASDAQ: CUTR) investors who suffered $100k losses or more to submit your losses now .
CUTR INVESTOR ALERT: Hagens Berman, National Trial Attorneys, Encourages Cutera (CUTR) Investors with $100k+ Losses to Contact Firm''s Attorneys, Securities Fraud Class Action Pending 2023/06/06 21:35:00 Benzinga
SAN FRANCISCO, June 06, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Cutera, Inc. (NASDAQ: CUTR ) investors who suffered $100k losses or more to submit your losses now . Class Period: Feb. 17, 2021 – May 9, 2023 Lead Plaintiff Deadline: July 24, 2023 Visit: www.hbsslaw.com/investor-fraud/CUTR Contact An Attorney Now: CUTR@hbsslaw.com 844-916-0895 Cutera, Inc. (CUTR) Securities Fraud Class Action: The litigation focuses on Cutera''s past assurances that it "is well-positioned to accelerate growth and expand profitability as the impact of COVID-19 continues to wane" and that its internal control over financial reporting is effective. The complaint alleges Defendants: (1) overstated the sustainability of Cutera''s revenue growth; (2) failed to disclose serious conflicts among the company''s senior management and its board of directors; and (3) failed to disclose several serious weaknesses in the company''s internal control over financial reporting. Investors learned the truth through a series of partial corrective disclosures.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Cutera, Inc. (CUTR) 2023/06/06 20:22:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 24, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Cutera, Inc. (“Cutera” or the “Company”) (NASDAQ: CUTR) common stock between February 17, 2021 and May 9, 2023, inclusive (the “Class Period”). If you suffered a loss on your Cutera investments or would like to inquire about potentially pursuing claims to
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Cutera, Inc. with Losses of $100,000 to Contact the Firm 2023/06/06 19:30:34 TodaysStocks.com
Los Angeles, California–(Newsfile Corp. – June 6, 2023) – The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a category motion lawsuit against Cutera, Inc. (“Cutera” or “the Company”) (NASDAQ: CUTR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the […] The post SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Cutera, Inc. with Losses of $100,000 to Contact the Firm appeared first on TodaysStocks.com .
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Cutera, and Luminar and Encourages Investors to Contact the Firm 2023/06/05 01:00:00 GlobeNewswire
NEW YORK, June 04, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Cutera, Inc. (NASDAQ: CUTR), and Luminar Technologies, Inc. (NASDAQ: LAZR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
HRT Financial LP Acquires Shares of 13,012 Cutera, Inc. (NASDAQ:CUTR) 2023/06/04 10:46:42 The AM Reporter
HRT Financial LP acquired a new stake in Cutera, Inc. (NASDAQ:CUTR – Get Rating) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 13,012 shares of the medical device company’s stock, valued at approximately $575,000. HRT Financial LP owned approximately 0.07% of Cutera at the […]
CUTERA INVESTOR ALERT: Kaplan Fox & Kilsheimer LLP Notifies CUTERA Investors of a Class Action Lawsuit and Upcoming Deadline 2023/06/01 14:55:00 GlobeNewswire
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) reminds investors that a complaint has been filed on behalf of purchasers of Cutera, Inc. (“Cutera” or the “Company”) common stock (NASDAQ: CUTR) between February 17, 2021 and May 9, 2023, inclusive (the “Class Period”). Cutera is a medical aesthetic device company that provides equipment for beauty treatments.
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Cutera, Inc. (CUTR) Investors 2023/06/01 14:30:00 Business Wire
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Cutera, Inc. (“Cutera” or the “Company”) (NASDAQ: CUTR) common stock between February 17, 2021 and May 9, 2023, inclusive (the “Class Period”). Cutera investors have until July 24, 2023 to file a lead plaintiff motion. If you suffered a loss on your Cutera investments
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Cutera, Inc. (CUTR) Investors and Encourages Investors to Contact the Firm Before July 24, 2023 2023/06/01 14:20:00 GlobeNewswire
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Nothern District of California on behalf of those who acquired Cutera, Inc. (“Cutera” or the “Company”) (NASDAQ: CUTR ) securities during the period from February 17, 2021 through May 9, 2023 (the “Class Period”). Investors have until July 24, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Cutera gets FDA warning letter over a website promoting a device for vaginal procedures 2022/12/01 22:16:03 Seeking Alpha
Cutera (CUTR) on Thursday said it had recently been issued a warning letter from the U.S. FDA regarding marketing material over a device that the company stopped promoting in 2019
Cutera, Inc. Provides Response to FDA Inquiry 2022/12/01 21:30:00 Wallstreet:Online
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today disclosed that it has provided a response to a recent FDA inquiry. In 2019, Cutera undertook remediation to remove all marketing materials related to gynecological indications, including vaginal rejuvenation, for a device designed and manufactured by a third party.
Cutera Stock: AviClear Key Differentiator, Reaffirm Buy (NASDAQ:CUTR) 2022/12/01 10:54:58 Seeking Alpha
AviClear revenue growth was the key standout for Cutera, with >160 devices now in the installed base. Find out why we rate CUTR stock a buy.
Cutera, Inc. to Participate in a Fireside Chat at the 34th Annual Piper Sandler Healthcare Conference 2022/11/21 22:00:00 Wallstreet:Online
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Dave Mowry, Chief Executive Officer, and Greg Barker, Vice President, Corporate FP&A, will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference at 2:00 pm ET on Wednesday, November 30, 2022, at the Lotte New York Palace
Cutera, Inc. to Participate in a Fireside Chat at the Stephens Annual Investment Conference 2022/11/10 22:10:00 Wallstreet:Online
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that Dave Mowry, Chief Executive Officer, and Greg Barker, Vice President, Corporate FP&A, will participate in a fireside chat at the Stephens Annual Investment Conference at 4:00 pm CT on Wednesday, November 16, 2022, at the Grand Hyatt Hotel, Nashville, TN.